1. 黄灿华 中国 四川大学 Drug resistance in colorectal cancer: An epigenetic overview
2. Alexander,Dobrovic 澳大利亚 University of Melbourne Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of P..
3. Iain A,McNeish 英国 Imperial College London Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of P..
4. Larry M,Karnitz 美国 Mayo Clinic - Rochester Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of P..
5. Elizabeth M,Swisher 美国 University of Washington Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of P..
6. Scott H,Kaufmann 美国 Mayo Clinic - Rochester Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of P..
7. Goel, Ajay 美国 Baylor University Epigenetics of colorectal cancer: biomarker and therapeutic potential
8. Fabio,Coppede 意大利 University of Pisa Pharmacoepigenetics and pharmacoepigenomics of gastrointestinal cancers
9. Tsai, Shih-Feng 中国 台湾国家卫生研究院 Hypermethylation of BEND5 contributes to cell proliferation and is a prognostic marker of colorectal..
10. Thomas M,Roberts 美国 Harvard University The emerging role of PI3K/AKT-mediated epigenetic regulation in cancer
11. 赵景 美国 Harvard University The emerging role of PI3K/AKT-mediated epigenetic regulation in cancer
12. 丁义涛 中国 南京大学 主任医师 USP39 promotes colorectal cancer growth and metastasis through the Wnt/beta-catenin pathway
13. Thomas,Wirth 德国 University of Ulm Activation of oncogenic pathways in classical Hodgkin lymphoma by decitabine: A rationale for combin..
14. 张学军 中国 安徽医科大学 所长 Lentivirus-mediated downregulation of MAT2B inhibits cell proliferation and induces apoptosis in mel..